CD274 and neoplasm: As the presence of tumor-infiltrating lymphocytes is a favorable prognostic factor in endometrial cancer and indicates an active role of the immune system, targeted therapies like PD-1/PD-L1 checkpoint inhibitors may have the potential to be effective in endometrial cancer [109].